Skip to content

Transcutaneous Acupoint Electrical Stimulation for Postoperative ICNB Syndrome in Breast Cancer: A Randomized Controlled Trial

Transcutaneous Acupoint Electrical Stimulation for Postoperative ICNB Syndrome in Breast Cancer: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000864
Enrollment
Unknown
Registered
2024-12-25
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Intercostobrachial Nevers Syndrome in Breast Cancer

Interventions

Control group:basic therapy and sham Transcutaneous Electrical Acupoint Stimulation treatment
Treatment group:basic therapy and Transcutaneous Electrical Acupoint Stimulation treatment

Sponsors

Yunnan Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for breast cancer; (2) Breast cancer patients undergoing unilateral total or breast-conserving surgery plus axillary lymph node dissection; (3) Patients who meet the diagnostic criteria for postoperative ICBNS for breast cancer; (4) Patients with unilateral non-metastatic breast cancer; (5) Aged between 25-75 years old; (6) Receiving follow-up treatment at our hospital after surgery; (7) Can communicate normally; (8) Expected survival > 12 months.

Exclusion criteria

Exclusion criteria: (1) Those who underwent radical mastectomy for breast cancer with preservation of the intercostal brachial nerve; (2) Patients who do not have breast cancer on final histologic examination; (3) Those who received other treatments before surgery have a history of chronic pain and take analgesic drugs and neurotrophic drugs for a long time; (4) History of breast surgery; (5) Pre-operative arm movement disorder or neuropathy; (6) Patients receiving other adjuvant treatments.

Design outcomes

Primary

MeasureTime frame
tactile assessment;upper extremity muscle strength;visual analogue scale;electromyography;constant-murley score;

Secondary

MeasureTime frame
Chinese medicine symptom score;functional assessment of cancer therapy-generic scale;

Countries

China

Contacts

Public ContactZhao Rong

Yunnan Provincial Hospital of TCM/ Yunnan University of Chinese Medicine

kmzhaorong@qq.com138 8865 9309

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 20, 2026